Insider Trading History of Grayzel David S.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Grayzel David S. since 2018. This trader's CIK number is 1732786. At the time of last reporting, Grayzel David S. was the Officer of Aerovate Therapeutics, Inc.. (stock ticker symbol AVTE). Also see all insider trading activities at Aerovate Therapeutics, Inc..

Note that in the past GRAYZEL DAVID S. also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Surface Oncology, Inc. (SURF) by Grayzel David S.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2020 SURF 0 $0 1,700,000 $30,770,000 0 $0
2018 SURF 100,000 $1,500,000 0 $0 0 $0

Yearly summary of insider trading at Aerovate Therapeutics, Inc. (AVTE) by Grayzel David S.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2024 AVTE 0 $0 11,882 $334,478 0 $0
2021 AVTE 535,714 $7,499,996 0 $0 0 $0


Insider trading activities at 2 companies by Grayzel David S.:

1. Surface Oncology, Inc. (SURF)

2. Aerovate Therapeutics, Inc. (AVTE)

Table 1. Insider trading of Surface Oncology, Inc. (SURF) by Grayzel David S.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2020-12-17 SURF Sale 1,700,000 18.10 30,770,000
2018-04-23 SURF Buy 100,000 15.00 1,500,000

Table 2. Insider trading of Aerovate Therapeutics, Inc. (AVTE) by Grayzel David S.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2024-04-09 AVTE Sale 11,882 28.15 334,478
2021-07-02 AVTE Buy 535,714 14.00 7,499,996

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Grayzel David S. (Officer of Aerovate Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.